Age Group – Page 2

Moderna’s RSV Vaccines Face Safety Concerns Over Severe Infections in Infants

6 months ago talkbio0Tagged Advisory Committees, concerns, Infant, Moderna, Respiratory syncytial virus, RNA, Messenger, Safety, United States Food and Drug Administration, Vaccines

Moderna, RSV vaccines, safety concerns, severe infections, infants, mRNA vaccines, FDA, advisory committee

CDC Recommends Pneumococcal Vaccination for Adults 50 Years and Older

8 months ago talkbio0Tagged Administration of vaccine product containing only Streptococcus pneumoniae antigen (procedure), Adult, Centers for Disease Control and Prevention (U.S.), older, pneumococcal disease prevention, Recommendation, respiratory season

Pneumococcal vaccination, CDC recommendations, adults 50 and older, pneumococcal disease prevention, winter respiratory season.

Bavarian Nordic’s Mpox Vaccine Demonstrates Equivalent Efficacy in Teens and Adults: NIH Study

8 months ago talkbio0Tagged Adolescent (age group), Adult, Antibodies, Bavarian Nordic, Effectiveness, mpox vaccine, MVA, MVA-BN vaccine, NIH, NIH Mouse, Response process, Safety

Mpox vaccine, Bavarian Nordic, MVA-BN vaccine, Teenagers, Adults, Antibody response, Safety, Efficacy, NIH study

GSK Advances Co-Administration of RSV and Shingles Vaccines with Positive Phase III Data

9 months ago talkbio0Tagged Adult, Arexvy, co-administration, Herpes zoster disease, Immunization, Phase III data, Respiratory syncytial virus, Shingrix, SmithKline Beecham, Vaccines

GSK, RSV vaccine, Shingles vaccine, Arexvy, Shingrix, co-administration, Phase III data, adult immunization

FDA Approves Revolutionary Re-Expandable Stent for Young Children

9 months ago talkbio0Tagged Approved, Child, Congenital Heart Defects, Minimally invasive procedure, re-expandable, Stent, device, United States Food and Drug Administration, Young

FDA approval, re-expandable stent, young children, congenital heart disease, minimally invasive procedures

Lilly’s Tirzepatide Demonstrates Significant Reduction in Diabetes Risk and Sustained Weight Loss in Overweight Adults

10 months ago talkbio0Tagged Adult, Diabetes, Eli, Eli Lilly, Mounjaro, Obesity, Overweight, Prediabetes syndrome, Risk Reduction, Sustained, Weight Loss, Zepbound

tirzepatide, diabetes risk reduction, sustained weight loss, overweight adults, pre-diabetes, obesity, Eli Lilly, Mounjaro, Zepbound

Aeterna Zentaris Rebrands as COSCIENS Biopharma: A New Era in Biopharmaceuticals

10 months ago talkbio0Tagged Adult, Aeterna Zentaris, Biological Factors, Biopharma, Changing, COSCIENS, development aspects, Diagnostic tests, Macrilen, rebranding, Somatotropin deficiency

Aeterna Zentaris, COSCIENS Biopharma, biopharmaceuticals, rebranding, name change, therapeutic development, diagnostic tests, Macrilen, adult growth hormone deficiency

BioMarin’s Brineura Receives Significant Label Expansion from FDA for Children Under 3 with CLN2 Disease

11 months ago talkbio0Tagged Alfa, BioMarin, Brineura, cerliponase, Child, Deterioration, expansion, Injection of therapeutic agent, Intraventricular, Labels (device), motor ability, Neurodegenerative, Symptoms aspect, TPP1 gene, United States Food and Drug Administration

BioMarin, Brineura, FDA, Label Expansion, CLN2 Disease, Children Under 3, Cerliponase Alfa, Intraventricular Injection, Motor Ability Deterioration, Neurodegenerative Symptoms